ClinicalTrials.Veeva

Menu

Identification of Cardiovascular Risk Factors Linked to Renal Failure Progression (Pre-HD)

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Completed

Conditions

Chronic Renal Failure

Study type

Observational

Funder types

Other

Identifiers

NCT00608998
7853 (Other Identifier)

Details and patient eligibility

About

The aim of this study is to appreciate the influence of renal failure progression on vasculopathy (coronary calcifications and left ventricular hypertrophy) and cardiovascular risk factors.

Full description

The aim of this study is to appreciate the relationship between:

  • extension of coronary calcifications and chronic renal failure progression
  • extension of coronary calcifications and levels of osteoprotegerin (bone disease marker)
  • cardiovascular risk factors and coronary calcifications
  • cardiovascular risk factors and existence of cardiovascular diseases

Enrollment

120 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient who has signed the written consent form

  • Patient aged > 18 and < 90 years

  • Chronic renal failure defined by glomerular filtration rate (GFR)

    • group 1: GFR >90 mL/min with urinary biological abnormalities and GFR comprised between 90 and 60 mL/min
    • group 2: GFR comprised between 60 and 30 mL/min
    • group 3: GFR <30 mL/min but without dialysis therapy

Exclusion criteria

  • Chronic renal failure patient requiring dialysis therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems